covid_cell_1_1

Pharmafile.com’s weekly COVID-19 news round-up

September 2, 2020
Research and Development

The COVID-19 news round-up this week focuses on coronavirus treatments, with Celltrion Group announcing that the Korean Ministry of Food …

index_ph001

Daiichi Sankyo’s Nilemdo “significantly” reduces cholesterol levels at ESC 2020

September 1, 2020
Manufacturing and Production, Research and Development Daiichi Sankyo, Nilemdo, pharma

Daiichi Sankyo has unveiled promising new benefit for Nilemdo (bempedoic acid) at the ESC Congress 2020 over the weekend for …

flu_vaccination_grippe_5115654021

Oxford University’s COVID-19 vaccine begins Phase 3 trial in the US

September 1, 2020
Manufacturing and Production

AstraZeneca has started a Phase 3 trial of its experimental coronavirus vaccines in the US, making it the third company …

800px-street_in_hong_kong_during_the_covid-19_pandemic

Hong Kong rolls out free universal coronavirus testing programme

September 1, 2020
Manufacturing and Production

Hong Kong has begun a free universal COVID-19 testing programme to help combat the coronavirus.  This mass testing system will …

800px-vaccine

Sanofi halts Phase 3 trial of Kevzara as a COVID-19 treatment

September 1, 2020
Manufacturing and Production COVID-19, Sanofi, Vaccine, pharma

Sanofi is halting clinical trials treating serious COVID-19 patients with its Kevzara drug after data on its efficacy proved inconclusive.The …

astrazeneca_plaque

AstraZeneca’s Farxiga combo shows promise at Phase 3 in late-stage chronic kidney disease

September 1, 2020
Manufacturing and Production AstraZeneca, ESC Congress 2020, pharma

AstraZeneca took the opportunity at the digital ESC Congress 2020 over the weekend to reveal promising new Phase 3 data …

3dmammogram

University of Illinois at Chicago’s new breast cancer drug is safe and can halt disease progression, according to a Phase 1 trial

August 28, 2020
Medical Communications Cancer, Cancers, breast cancer

A new breast cancer drug, called TTC-352, can halt the spread of the disease and is safe according to a …

49720569077_fac396d536_b

US signs deal to buy 150 million rapid COVID-19 tests from Abbott

August 28, 2020
Medical Communications

The US government has signed a deal to buy Abbott’s rapid coronavirus test after the FDA gave it Emergency Use …

800px-lsd_tabs

First clinical trial for MDMA and LSD combination set to go ahead

August 28, 2020
Medical Communications LSD, MDMA, PTSD

Researchers are set to investigate a combined dose of LSD and MDMA to treat patients undergoing psychotherapy. The Phase 1 …

200707-f-zc102-1004

Korea approves Celltrion’s Phase 1 trial of COVID-19 antiviral antibody treatment

August 28, 2020
Medical Communications COVID-19, antibodies, coronavirus vaccine

Celltrion Group has announced that the Korean Ministry of Food and Drug Safety has approved the company’s Investigational New Drug …

top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

August 28, 2020
Medical Communications COVID-19, Vaccine, coronavirus vaccine, top 10

The top 10 news stories this week are focused on coronavirus vaccines and treatments, as China is set to move …

hamburger-cheeseburger-burger-bun

Obesity increases risk of death from coronavirus and could make vaccines less effective

August 27, 2020
Medical Communications obesity

Obesity can increase the risk of death from coronavirus by nearly 50% and could make a vaccine less effective, according …

covid_innovations_bamc_1

Genexine’s cytokine drug effective in treating coronavirus patients, new study suggests

August 27, 2020
Research and Development COVID-19

Genexine’s recent clinical trial investigating how its cytokine therapy treats coronavirus has proven effective, according to the company. 

flu_shot_2019_1

Moderna says its COVID-19 vaccine shows promise in elderly patients

August 27, 2020
Research and Development Moderna vaccine, Operation Warp Speed

Moderna has announced that its coronavirus vaccine candidate has shown promise in generating an immune response in elderly patients in …

fda_21

FDA approves Abbott’s rapid portable COVID-19 test

August 27, 2020
Research and Development Abbott, COVID-19, FDA, test

The FDA has given emergency clearance for Abbott’s portable COVID-19 test that it will sell for just $5.  The company’s …

800px-temazepam_10mg_tablets-1_1

Canada to roll out automated drug dispensers to help fight opioid crisis

August 27, 2020
Research and Development opioid, opioid crisis, opioids

Canada is set to roll out automated drug dispensers that can provide clean, doctor-prescribed medicine to opioid addicts by scanning …

800px-nhs_nnuh_entrance_2

Thousands of coronavirus cases recorded in hospital were caught on site, new research suggests

August 26, 2020
Research and Development coronavirus

Thousands of coronavirus cases are thought to have been transmitted within UK hospitals, according to a new study. Researchers at …

unnamed_1

US Department of Justice charges Teva with generic price fixing

August 26, 2020
Research and Development Department of Justice, Teva Pharmaceuticals

The US Department of Justice (DOJ) has charged Teva Pharmaceuticals with conspiracy to fix the price of its generic drugs. …

75-year-old Nottinghamshire woman may be first known British victim of coronavirus

August 26, 2020
Research and Development COVID-19, coronavirus

A 75-year-old woman from Nottinghamshire is thought to be the first British case and victim of COVID-19. She tested positive …

8330379372_1e55f3c4c2_b

Africa declared free of wild polio

August 26, 2020
Research and Development polio, vaccines

The Africa Regional Certification Commission has declared Africa to be free from wild polio. Nigeria, Pakistan and Afghanistan were the …

The Gateway to Local Adoption Series

Latest content